THRM 10-Q Quarterly Report Sept. 30, 2013

GENTHERM INC

10-Ks and 10-Qs

10-Q	Quarter ended Sept. 30, 2025
10-Q	Quarter ended June 30, 2025
10-Q	Quarter ended March 31, 2025
10-K	Fiscal year ended Dec. 31, 2024
10-Q	Quarter ended Sept. 30, 2024
10-Q	Quarter ended June 30, 2024
10-Q	Quarter ended March 31, 2024
10-K	Fiscal year ended Dec. 31, 2023
10-Q	Quarter ended Sept. 30, 2023
10-Q	Quarter ended June 30, 2023
10-Q	Quarter ended March 31, 2023
10-K	Fiscal year ended Dec. 31, 2022
10-Q	Quarter ended Sept. 30, 2022
10-Q	Quarter ended June 30, 2022
10-Q	Quarter ended March 31, 2022
10-K	Fiscal year ended Dec. 31, 2021
10-Q	Quarter ended Sept. 30, 2021
10-Q	Quarter ended June 30, 2021
10-Q	Quarter ended March 31, 2021
10-K	Fiscal year ended Dec. 31, 2020
10-Q	Quarter ended Sept. 30, 2020
10-Q	Quarter ended June 30, 2020
10-Q	Quarter ended March 31, 2020
10-K	Fiscal year ended Dec. 31, 2019
10-Q	Quarter ended Sept. 30, 2019
10-Q	Quarter ended June 30, 2019
10-Q	Quarter ended March 31, 2019
10-K	Fiscal year ended Dec. 31, 2018
10-Q	Quarter ended Sept. 30, 2018
10-Q	Quarter ended June 30, 2018
10-Q	Quarter ended March 31, 2018
10-K	Fiscal year ended Dec. 31, 2017
10-Q	Quarter ended Sept. 30, 2017
10-Q	Quarter ended June 30, 2017
10-Q	Quarter ended March 31, 2017
10-K	Fiscal year ended Dec. 31, 2016
10-Q	Quarter ended Sept. 30, 2016
10-Q	Quarter ended June 30, 2016
10-Q	Quarter ended March 31, 2016
10-K	Fiscal year ended Dec. 31, 2015
10-Q	Quarter ended Sept. 30, 2015
10-Q	Quarter ended June 30, 2015
10-Q	Quarter ended March 31, 2015
10-K	Fiscal year ended Dec. 31, 2014
10-Q	Quarter ended Sept. 30, 2014
10-Q	Quarter ended June 30, 2014
10-Q	Quarter ended March 31, 2014
10-K	Fiscal year ended Dec. 31, 2013
10-Q	Quarter ended Sept. 30, 2013
10-Q	Quarter ended June 30, 2013
10-Q	Quarter ended March 31, 2013
10-K	Fiscal year ended Dec. 31, 2012
10-Q	Quarter ended Sept. 30, 2012
10-Q	Quarter ended June 30, 2012
10-Q	Quarter ended March 31, 2012
10-K	Fiscal year ended Dec. 31, 2011
10-Q	Quarter ended Sept. 30, 2011
10-Q	Quarter ended June 30, 2011
10-Q	Quarter ended March 31, 2011
10-K	Fiscal year ended Dec. 31, 2010
10-Q	Quarter ended Sept. 30, 2010
10-Q	Quarter ended June 30, 2010
10-Q	Quarter ended March 31, 2010
10-K	Fiscal year ended Dec. 31, 2009

PROXIES

DEF 14A	Filed on May 8, 2025
DEF 14A	Filed on March 27, 2025
DEF 14A	Filed on May 16, 2024
DEF 14A	Filed on April 4, 2024
DEF 14A	Filed on April 6, 2023
DEF 14A	Filed on June 2, 2022
DEF 14A	Filed on April 21, 2022
DEF 14A	Filed on April 7, 2021
DEF 14A	Filed on April 21, 2020
DEF 14A	Filed on April 16, 2019
DEF 14A	Filed on April 17, 2018
DEF 14A	Filed on April 18, 2017
DEF 14A	Filed on April 25, 2016
DEF 14A	Filed on April 27, 2015
DEF 14A	Filed on April 14, 2014
DEF 14A	Filed on April 22, 2013
DEF 14A	Filed on July 25, 2012
DEF 14A	Filed on April 13, 2012
DEF 14A	Filed on May 20, 2011
DEF 14A	Filed on April 19, 2010

10-Q 1 thrm-10q_20130930.htm 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2013

¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______ to ______.

Commission File Number: 0-21810

GENTHERM INCORPORATED

(Exact name of registrant as specified in its charter)

Michigan		95-4318554
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

21680 Haggerty Road, Ste. 101, Northville, MI		48167
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (248) 504-0500

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):


Large accelerated filer	¨	Accelerated filer	x
Non-accelerated filer	¨	Smaller reporting company	¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

At November 1, 2013, the registrant had 34,689,569 shares of Common Stock, no par value, issued and outstanding.

GENTHERM INCORPORATED

TABLE OF CONTENTS


Cover

Table of Contents		2

Part I. Financial Information		3

Item 1.	Financial Statements (Unaudited)	3

	Consolidated Condensed Balance Sheets	3

	Consolidated Condensed Statements of Operations	4

	Consolidated Condensed Statements of Comprehensive Income	5

	Consolidated Condensed Statements of Cash Flows	6

	Consolidated Condensed Statement of Changes in Shareholders’ Equity	7

	Notes to Unaudited Consolidated Condensed Financial Statements	8

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	17

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	24

Item 4.	Controls and Procedures	28

Part II. Other Information		29

Item 1.	Legal Proceedings	29

Item 1A.	Risk Factors	29

Item 6.	Exhibits	29

Signatures		33

PART I. FINANCIAL INFORMATION

ITEM 1.

FINANCIAL STATEMENTS

GENTHERM INCORPORATED

CONSOLIDATED CONDE NSED BALANCE SHEETS

(In thousands, except share data)

	September 30, 2013			December 31, 2012
	(unaudited)
ASSETS
Current Assets:
Cash & cash equivalents	$	36,003		$	58,152
Accounts receivable, less allowance of $2,878 and $2,474, respectively		122,330			102,261
Inventory:
Raw Materials		35,388			28,279
Work in process		2,720			2,461
Finished goods		24,698			23,016
Inventory, net		62,806			53,756
Derivative financial instruments		292			160
Deferred income tax assets		14,389			15,006
Prepaid expenses and other assets		15,222			12,809
Total current assets		251,042			242,144
Property and equipment, net		73,608			55,010
Goodwill		25,300			24,729
Other intangible assets		85,827			95,870
Deferred financing costs		1,246			1,880
Deferred income tax assets		7,772			5,361
Derivative financial instruments		2,403			4,141
Other non-current assets		10,701			10,062
Total assets	$	457,899		$	439,197
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities:
Accounts payable	$	55,176		$	42,508
Accrued liabilities		57,696			54,157
Current maturities of long-term debt		22,164			17,218
Derivative financial instruments		2,652			3,326
Total current liabilities		137,688			117,209
Pension benefit obligation		4,961			5,009
Other liabilities		2,836			4,540
Long-term debt, less current maturities		65,270			39,734
Derivative financial instruments		9,553			13,245
Deferred income tax liabilities		21,945			21,828
Total liabilities		242,253			201,565
Series C Convertible Preferred Stock		—			22,469
Shareholders’ equity:
Common Stock:
No par value; 55,000,000 shares authorized, 34,689,569 and 29,818,225 issued and outstanding at September 30, 2013 and December 31, 2012, respectively		228,985			166,309
Paid-in capital		(9,076	)		24,120
Accumulated other comprehensive income (expense)		(9,308	)		(11,231	)
Accumulated earnings		3,854			(17,383	)
Total Gentherm Incorporated shareholders’ equity		214,455			161,815
Non-controlling interest		1,191			53,348
Total shareholders’ equity		215,646			215,163
Total liabilities and shareholders’ equity	$	457,899		$	439,197

See accompanying notes to the consolidated condensed financial statements.

GENTHERM INCORPORATED

CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

(Unaudited)

	Three Months Ended September 30,						Nine Months Ended September 30,
	Three Months Ended September 30,						Nine Months Ended September 30,
	2013			2012			2013			2012
Product revenues	$	171,182		$	141,058		$	479,792		$	406,737
Cost of sales		125,265			104,203			354,672			303,110
Gross margin		45,917			36,855			125,120			103,627
Operating expenses:
Net research and development expenses		12,718			10,257			36,962			30,566
Acquisition transaction expenses		326			—			1,911			—
Selling, general and administrative		18,319			16,560			53,483			45,972
Total operating expenses		31,363			26,817			92,356			76,538
Operating income		14,554			10,038			32,764			27,089
Interest expense		(1,062	)		(898	)		(2,916	)		(3,082	)
Revaluation of derivatives		217			(993	)		1,201			(1,056	)
Foreign currency gain (loss)		(1,612	)		(421	)		(1,514	)		2,357
Income (loss) from equity investment		77			3			319			(228	)
Other income		191			310			691			859
Earnings before income tax		12,365			8,039			30,545			25,939
Income tax expense		3,600			2,366			6,343			7,324
Net income		8,765			5,673			24,202			18,615
Gain attributable to non-controlling interest		(63	)		(1,672	)		(1,340	)		(4,491	)
Net income attributable to Gentherm Incorporated		8,702			4,001			22,862			14,124
Convertible preferred stock dividends		(159	)		(1,516	)		(1,622	)		(5,521	)
Net income attributable to common shareholders	$	8,543		$	2,485		$	21,240		$	8,603
Basic earnings per share	$	0.25		$	0.08		$	0.64		$	0.31
Diluted earnings per share	$	0.24		$	0.08		$	0.63		$	0.30
Weighted average number of shares – basic		34,447			29,619			33,261			28,177
Weighted average number of shares – diluted		34,886			30,003			33,584			28,676

See accompanying notes to the consolidated condensed financial statements.

GENTHERM INCORPORATED

CONSOLIDATED CONDENSED S TATEMENTS OF COMPREHENSIVE INCOME

(In thousands)

(Unaudited)

	Nine Months Ended September 30,
	2013			2012
Net income	$	24,202		$	18,615
Other comprehensive income, net of tax:
Foreign currency translation adjustments		1,848			1,649
Unrealized gain (loss) on interest rate derivative securities		105			(55	)
Foreign currency translation adjustments from deferred tax		(197	)		—
Other comprehensive loss, net of tax	$	1,756		$	1,594
Comprehensive income		25,958			20,209
Less: comprehensive income attributable to the non-controlling interest		1,173			4,844
Comprehensive income attributable to Gentherm Incorporated	$	24,785		$	15,365

See accompanying notes to the consolidated condensed financial statements.

gentherm INCORPORATED

CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

	Nine Months Ended September 30,
	2013			2012
Operating Activities:
Net income	$	24,202		$	18,615
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization		23,467			22,737
Deferred tax provision		(1,138	)		2,134
Stock compensation		1,861			911
Defined benefit plan expense		(159	)		(303	)
Provision of doubtful accounts		369			(305	)
Gain on revaluation of financial derivatives		(2,859	)		(1,064	)
Loss (gain) on equity investment		(318	)		228
Loss on sale of property, plant and equipment		48			53
Excess tax benefit from equity awards		(1,317	)		(1,577	)
Changes in operating assets and liabilities:
Accounts receivable		(19,606	)		(16,728	)
Inventory		(8,824	)		(4,250	)
Prepaid expenses and other assets		(2,458	)		(7,264	)
Accounts payable		11,250			4,622
Accrued liabilities		4,099			10,715
Net cash provided by operating activities		28,617			28,524
Investing Activities:
Purchase of non-controlling interest		(46,835	)		—
Purchase of derivative financial instruments		—			(7,787	)
Proceeds from the sale of property, plant and equipment		7			20
Purchase of property and equipment		(30,016	)		(15,344	)
Loan to equity investment		—			(590	)
Cash invested in corporate owned life insurance		(266	)		(265	)
Patent costs		—			(1,744	)
Net cash used in investing activities		(77,110	)		(25,710	)
Financing Activities:
Borrowing of debt		48,923			3,286
Repayments of debt		(18,966	)		(19,149	)
Distributions paid to non-controlling interests		(3	)		(290	)
Proceeds from public offering of common stock		—			75,487
Excess tax benefit from equity awards		1,317			1,577
Cash paid to Series C Preferred Stock Holders		(9,142	)		(17,340	)
Proceeds from sale of W.E.T. equity to non-controlling interest		—			1,921
Proceeds from the exercise of Common Stock options		2,901			733
Net cash provided by financing activities		25,030			46,225
Foreign currency effect		1,314			(599	)
Net increase (decrease) in cash and cash equivalents		(22,149	)		48,440
Cash and cash equivalents at beginning of period		58,152			23,839
Cash and cash equivalents at end of period	$	36,003		$	72,279
Supplemental disclosure of cash flow information:
Cash paid for taxes	$	7,174		$	5,678
Cash paid for interest	$	2,249		$	2,787
Supplemental disclosure of non-cash transactions:
Common stock issued to Board of Directors and employees	$	1,028		$	314
Issuance of common stock to non-controlling interest	$	42,517		$	—
Issuance of common stock for Series C Preferred Stock conversion	$	15,508		$	—

See accompanying notes to the consolidated condensed financial statements.

Gentherm INCORPORATED

CONSOLIDATED CONDENSED STATEMENT OF CHANGES IN SHAREHOLDERS’ EQUITY

(In thousands)

(Unaudited)

	Common Stock				Paid-in Capital			Accumulated Earnings			Accumulated Other Comprehensive Loss			Total Gentherm Equity			Non- Controlling Interest			Total
	Shares		Amount		Paid-in Capital			Accumulated Earnings			Accumulated Other Comprehensive Loss			Total Gentherm Equity			Non- Controlling Interest			Total
Balance at December 31, 2012		29,818	$	166,309	$	24,120		$	(17,383	)	$	(11,231	)	$	161,815		$	53,348		$	215,163
Exercise of Common Stock options for cash		437		4,023		(1,122	)		—			—			2,901			—			2,901
Tax benefit from Exercises of Common Stock options		—		—		1,317			—			—			1,317			—			1,317
Stock issued upon conversion of preferred stock		954		15,108		—			—			—			15,108			—			15,108
Stock option compensation		—		—		833			—			—			833			—			833
Common Stock issued to Board of Directors and employees		180		1,028		—			—			—			1,028			—			1,028
Convertible preferred stock dividends		—		—		—			(1,622	)		—			(1,622	)		—			(1,622	)
Acquisition of non-controlling interest		3,300		42,517		(34,224	)		—			—			8,293			(53,327	)		(45,034	)
Distribution paid to non-controlling interest		—		—		—			(3	)		—			(3	)		(3	)		(6	)
Interest rate hedge, net		—		—		—			—			105			105			—			105
Currency translation, net		—		—		—			—			2,015			2,015			(167	)		1,848
Currency translation from deferred taxes, net		—		—		—			—			(197	)		(197	)		—			(197	)
Net income		—		—		—			22,862			—			22,862			1,340			24,202
Balance at September 30, 2013		34,689	$	228,985	$	(9,076	)	$	3,854		$	(9,308	)	$	214,455		$	1,191		$	215,646

See accompanying notes to the consolidated condensed financial statements.

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

Note 1 – The Company and Subsequent Event

Gentherm Incorporated is a leading supplier of thermal seat comfort and cable systems to the global automotive industry. Unless the context otherwise requires, the terms “Gentherm”, “Company”, “we”, “us” and “our” used herein refer to Gentherm Incorporated. The term “historical Gentherm” used herein excludes W.E.T. Automotive Systems AG (“W.E.T.”), a subsidiary of Gentherm Incorporated. The Company performs design, development and manufacturing functions in locations aligned with our major customers’ product strategies in order to grow and expand our business around the globe. We are working to expand application of our existing technologies into new markets and products and to develop and refine new technologies to improve our existing products.

On February 22, 2013, historical Gentherm acquired an additional 442,253 shares in W.E.T., representing approximately 14% of the total outstanding shares in W.E.T., through a transaction agreement with W.E.T.’s largest minority shareholder. The Company paid 3,300,000 shares of Gentherm common stock and cash of €5,408, or $7,247, for these shares. As of September 30, 2013, we had acquired an additional 309,537 shares in W.E.T., raising our total ownership interest in W.E.T. above 99%. These additional shares were purchased at a price of €85 per share for a total of €26,311, or $35,256. Gentherm borrowed an additional $40,441 from the US Bank of America credit facility in connection with the purchase of these shares. See Note 6 below for additional information about the US Bank of America credit facility.

On February 22, 2013, the Company registered a Domination and Profit and Loss Transfer Agreement (“DPLTA”) in Germany with respect to W.E.T. The DPLTA essentially allows historical Gentherm and W.E.T. to be managed as one operational entity.

Subsequent Event

On October 31, 2013, the Company announced that it had registered a squeeze-out transaction in Germany and now owns 100 percent of the outstanding shares of W.E.T. As a result of the squeeze-out, the remaining shares of W.E.T., representing less than one percent of W.E.T.’s outstanding shares, were transferred to Gentherm and the applicable minority shareholders are entitled to receive €90.05 per share held at the time of registration.

Note 2 – Basis of Presentation and New Accounting Pronouncements

The accompanying unaudited consolidated condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments, consisting of normal recurring items, considered necessary for a fair presentation have been included. The balance sheet as of December 31, 2012 was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America. Operating results for the nine month period ended September 30, 2013 are not necessarily indicative of the results that may be expected for the year ending December 31, 2013. It is suggested that these consolidated condensed financial statements be read in conjunction with the financial statements and the notes thereto for the year ended December 31, 2012 included in our Annual Report on Form 10-K.

Hedge Accounting

In July 2013, the Financial Accounting Standards Board (FASB) issued ASU 2013-10 which permits the use of the Overnight Index Swap Rate (OIS), also referred to as the Fed Fund Effective Swap Rate as a U.S. GAAP benchmark interest rate for hedge accounting purposes under Topic 815. Currently, only the interest rates on direct Treasury obligations of the U.S. government (UST) and the London Interbank Offered Rate (LIBOR) swap rate are considered benchmark interest rates in the United States. This update also removes the restriction on using different benchmark rates for similar hedges. Including the Fed Funds Effective Swap Rate as an acceptable U.S. benchmark interest rate in addition to UST and LIBOR will provide risk managers with a more comprehensive spectrum of interest rate resets to utilize as the designated interest risk component under the hedge accounting guidance in Topic 815. The amendments of this ASU are effective prospectively for qualifying new or redesignated hedging relationships entered into on or after July 17, 2013.

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

Note 2 – Basis of Presentation and New Accounting Pronouncements – Continued

We do not anticipate that the adoption of this guidance will have a material effect on our consolidated balance sheet or statement of operations.

Unrecognized Tax Benefits

ASU 2013-11, issued in July 2013, requires that an unrecognized tax benefit be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward. When a net operating loss, a similar tax loss, or a tax credit carryforward is not available at the reporting date under the tax law of the applicable jurisdiction to settle any additional taxes that would result from the disallowance of a tax position, or the tax law of the applicable jurisdiction does not require the entity to use, and the entity does not intend to use, the deferred tax asset for such purposes, the unrecognized tax benefit should be presented in the financial statements as a liability. The assessment of whether a deferred tax asset is available is based on the unrecognized tax benefit and deferred tax asset that exist at the reporting date and should be made presuming disallowance of the tax position at the reporting date.

ASU 2013-11 is effective for fiscal years and interim periods beginning after December 15, 2013 and should be applied prospectively to all unrecognized tax benefits that exist at the effective date. As Gentherm already nets together an unrecognized tax benefit associated with a deferred tax asset from tax credit carryforwards, we do not anticipate an impact to our consolidated balance sheet resulting from the adoption of this guidance.

Tax Regulation

The Company is evaluating the impact of the regulations concerning amounts paid to acquire, produce, or improve tangible property and recovery of basis upon disposition. Because the revenue procedures governing the tangible property regulations will not be issued until the fourth quarter, the Company is still determining whether or not any changes in accounting method will be required and if they will result in a material impact to its financial statements. At this time, the Company does not anticipate there being a material impact.

Note 3 – Earnings per Share

Basic earnings per common share are computed by dividing net income by the weighted average number of shares of stock outstanding. The Company’s diluted earnings per common share give effect to all potential shares of Common Stock outstanding during a period that are not anti-dilutive. In computing the diluted earnings per share, the treasury stock and if converted methods are used in determining the number of shares assumed to be purchased from the conversion of Common Stock equivalents.

The following summarizes the amounts included in the dilutive shares as disclosed on the face of the consolidated condensed statements of operations:

	Three Months Ended September 30,			Nine Months Ended September 30,
		2013	2012		2013	2012
Weighted average number of shares for calculation of basic EPS – Common Stock		34,447,098	29,618,964		33,261,115	28,177,182
Impact of stock options outstanding under the 1997, 2006 and 2011 Stock Option Plans		439,364	384,383		323,111	498,461
Weighted average number of shares for calculation of diluted EPS		34,886,462	30,003,347		33,584,226	28,675,643

The accompanying table represents Common Stock issuable upon the exercise of certain stock options, the Series C Convertible Preferred Stock and potential dividends paid in common stock that have been excluded from the diluted shares calculation because the effect of their inclusion would be anti-dilutive.

	Three Months Ended September 30,			Nine Months Ended September 30,
		2013	2012		2013	2012
Stock options outstanding under the 2006, 2011 and 2013 Stock Option Plans		500,000	584,586		508,000	584,586
Series C Convertible Preferred Stock		—	2,092,291		—	2,092,291
		500,000	2,676,877		508,000	2,676,877

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

Note 4 – Segment Reporting

Segment information is used by management for making operating decisions and assessing the performance of the Company. Management evaluates the performance of its segments based primarily on operating income.

The Company’s reportable segments are as follows:

Climate Control Seats (CCS) – variable temperature seat climate control system designed to improve the temperature comfort of automobile passengers. This segment also includes the heated and cooled cup holder and heated and cooled mattress divisions. This segment represents historical Gentherm business only. It does not include seat climate control products of historical W.E.T.

Advanced Technology – a division engaged in research and development efforts to improve the efficiency of thermoelectric devices and to develop, market and distribute products based on this new technology. It includes U.S. Department of Energy sponsored research projects, such as the development of a commercially viable thermoelectric generator.

·	W.E.T. Automotive AG (W.E.T.) – W.E.T. is being evaluated currently as an individual segment until such time as Gentherm is able to fully evaluate and implement its future integration plans and strategy.

The tables below present segment information about the reported product revenues and operating income of the Company for the three month period ended September 30, 2013 and 2012. With the exception of goodwill, asset information by segment is not reported since the Company does not manage assets at a segment level at this time. Goodwill as of September 30, 2013 and 2012 pertained entirely to our W.E.T. segment.

Three Months Ended September 30,	CCS		Advanced Technology			W.E.T.		Reconciling Items			Consolidated Total
2013:
Product revenues	$	37,697	$	—		$	133,485	$	—		$	171,182
Depreciation and amortization		437		117			6,870		313			7,737
Operating income (loss)		11,152		(1,544	)		11,297		(6,351	)		14,554
2012:
Product revenues	$	33,966	$	—		$	107,092	$	—		$	141,058
Depreciation and amortization		329		82			6,692		342			7,445
Operating income (loss)		9,328		(1,631	)		8,249		(5,908	)		10,038

The Advanced Technology operating loss for the three months ended September 30, 2013 and 2012 is net of $375 and $656, respectively, of reimbursed research and development costs. Reconciling items include historical Gentherm’s corporate selling, general and administrative costs and acquisition transaction costs.

Nine Months Ended September 30,	CCS		Advanced Technology			W.E.T.		Reconciling Items			Consolidated Total
2013:
Product revenues	$	103,460	$	—		$	376,332	$	—		$	479,792
Depreciation and amortization		1,115		344			21,143		865			23,467
Operating income (loss)		28,953		(5,174	)		28,407		(19,422	)		32,764
2012:
Product revenues	$	96,117	$	—		$	310,620	$	—		$	406,737
Depreciation and amortization		787		388			20,697		865			22,737
Operating income (loss)		25,037		(5,260	)		22,274		(14,962	)		27,089

The Advanced Technology operating loss for the nine months ended September 30, 2013 and 2012 is net of $1,597 and $1,763, respectively, of reimbursed research and development costs. Reconciling items include historical Gentherm’s corporate selling, general and administrative costs and acquisition transaction costs.

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

Note 4 – Segment Reporting – Continued

Total product revenues information by geographic area:

	Three Months Ended September 30,
	2013				2012
United States	$	76,543	45	%	$	60,012	42	%
Germany		20,847	12	%		17,773	13	%
China		18,285	11	%		15,694	11	%
South Korea		13,546	8	%		10,716	8	%
Japan		10,281	6	%		10,294	7	%
United Kingdom		5,180	3	%		3,407	2	%
Mexico		4,230	2	%		3,581	3	%
Czech Republic		4,114	2	%		4,375	3	%
Canada		3,432	2	%		2,782	2	%
Other		14,724	9	%		12,424	9	%
Total product revenues	$	171,182	100	%	$	141,058	100	%

	Nine Months Ended September 30,
	2013				2012
United States	$	211,462	44	%	$	173,233	43	%
Germany		61,332	13	%		49,405	12	%
China		47,972	10	%		43,510	11	%
South Korea		39,069	8	%		31,213	8	%
Japan		28,591	6	%		24,014	6	%
United Kingdom		13,319	3	%		12,959	3	%
Czech Republic		11,893	3	%		12,102	3	%
Mexico		11,696	2	%		11,467	3	%
Canada		10,533	2	%		9,527	2	%
Other		43,925	9	%		39,307	10	%
Total product revenues	$	479,792	100	%	$	406,737	100	%

Note 5 – Series C Convertible Preferred Stock

In March 2011, the Company issued 7,000 shares of our Series C Convertible Preferred Stock (each a “Preferred Share” and, collectively, the “Preferred Shares”) having an initial stated value of $10,000 per Preferred Share, subject to adjustment. We received approximately $64,013 in net proceeds from the sale, after deducting placement agent fees and other offering expenses which totaled $5,987. We used the net proceeds from this offering to fund, in part, the W.E.T. acquisition.

Holders of the Series C Convertible Preferred Stock were entitled to receive, out of funds legally available therefore, dividends payable in cash (if permitted under the US Bank of America credit facility), our Common Stock (if certain equity conditions are satisfied or waived as of the applicable date), or any combination thereof, at the election of the Company, at the rate of 8% per annum of the stated value, payable quarterly in arrears on September 1, December 1, March 1 and June 1 of each year, commencing September 1, 2011. Dividends on our Series C Convertible Preferred Stock are cumulative from the date of initial issuance.

The Series C Convertible Preferred Stock was to be redeemed in nine equal quarterly installments that began on September 1, 2011 and ended September 1, 2013 (each, an “Amortization Date”) by paying cash, issuing shares of our Common Stock or any combination thereof for $10,000 per Preferred Share plus accumulated and unpaid dividends.

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

Note 5 – Series C Convertible Preferred Stock – Continued

Holders of the Series C Convertible Preferred Stock could have converted their shares at any time into shares of common stock at a conversion price of $15.83, including the conversion of accrued but unpaid dividends per Preferred Share then remaining into shares of common stock, and in addition would be entitled to a make-whole amount that would apply in a conversion (reflecting dividends that would have been payable through maturity if the Series C Convertible Preferred Stock had remained outstanding); provided, however, that under certain conditions where our US Bank of America credit facility prohibits payment of the make-whole amount, we would only be obligated to pay such make-whole amount at the time such amount, or portion thereof, would have been due to be paid as a dividend as if the Series C Convertible Preferred Stock at issue had not been converted.

In March 2013, holders of the Series C Convertible Preferred Stock elected to convert 165 shares into shares of common stock at the conversion price of $15.83 per share. The Company issued approximately 105,000 shares of common stock related to the conversion of Series C Convertible Preferred Stock.

In May 2013, holders of the Series C Convertible Preferred Stock elected to convert 650 shares into shares of common stock at the conversion price of $15.83 per share. The Company issued approximately 418,000 shares of common stock related to the conversion of Series C Convertible Preferred Stock.

During the months of July and August, 2013, holders of the Series C Convertible Preferred Stock elected to convert all unredeemed remaining shares of common stock at the conversion price of $15.83 per share. The Company issued approximately 432,000 shares of common stock related to the conversion of Series C Convertible Preferred Stock.

Total Series C Convertible Preferred Stock installments paid in cash during the nine months period ended September 30, 2013 is as follows:

	Installment Payments ($)
Dividend	$	696
Principal		8,446
Total	$	9,142

Note 6 – Debt

Gentherm, Inc. and our subsidiary, Gentherm Europe, have entered into a credit agreement with a syndicate of banks led by Bank of America (the “US Bank of America credit facility”). W.E.T., a subsidiary of Gentherm Europe, has also entered into a credit facility with the same syndicate of banks (the “W.E.T. Bank of America credit facility”).

The US Bank of America credit facility provided two term notes (referred to as the “US Term Note and Europe Term Note”) and a revolving line of credit note (“US Revolving Note”). The W.E.T. Bank of America credit facility provided W.E.T. with a term note (“W.E.T. Term Note”) and a revolving line of credit note (“W.E.T. Revolving Note”).

The US Term Note and Europe Term Note are subject to quarterly principal payments, with total principal amortization of 10% of the original principal amount in the first year and amortization of 12.5%, 15%, 17.5% and 10% of the original principal amount during years two, three, four and five, respectively with all remaining amounts owing under each term facility due and payable in full at the term loan maturity date. The W.E.T. Term Note is subject to quarterly principal payments totaling 20% annually. Principal outstanding under the two credit facilities will be due and payable in full on March 30, 2016. Interest is payable at least quarterly. The Company has the option to elect interest rates based on either a Eurocurrency (LIBOR or EURIBOR) rate (“Eurocurrency Rate Loans”) (0.17% – 0.45% at September 30, 2013) or a base rate (“Base Rate Loans”) plus a margin (“Applicable Rate”), which varies based on the Consolidated Leverage Ratio of the Company, as defined by the US and W.E.T. Bank of America credit agreements. The base rate is equal to the highest of the Federal Funds Rate (0.06% at September 30, 2013) plus 0.5%, Bank of America’s prime rate (3.25% at September 30, 2013), or a one month Eurocurrency rate plus 1.0%. The Applicable Rate for the current period was 2.25% for Eurocurrency Rate Loans and 1.25% for Base Rate Loans. The Company must maintain a minimum Consolidated Fixed Charge Coverage Ratio and a maximum Leverage Ratio, as defined by the Bank of America credit agreement. The loans are secured by all of the Company’s assets.

In February 2013, the Company made a $40,441 draw on the existing Europe Term Note portion of the US Bank of America credit facility to finance the purchase of shares of WET held by non-controlling interests. The Europe Term Note has expired and additional draws are not available to Gentherm.

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

Note 6 – Debt – Continued

In September 2012, we borrowed CN¥20,000, or $3,159, from Bank of China to fund a plant expansion project in China. The Bank of China loan was paid in full on September 10, 2013 with interest calculated at a fixed rate of 6.9%.

In May 2013, the Company made an initial draw of €2,000, or $2,601, on a loan from the German Investment Corporation, a subsidiary of KfW banking group, a German government-owned development bank (“DEG Loan”), to fund the China plant expansion project. An additional draw of €2,000, or $2,701, was made in September and the entire loan balance was rolled into a fixed interest rate loan with an interest rate of 3% plus a Euro Swap Rate of 1.25%. The Bank of China short term financing used to complete the project was repaid from funds available under the DEG Loan. The DEG Loan is subject to semi-annual principal payments beginning March, 2015 and ending September, 2019. Under the terms of the loan, the Company must maintain a minimum Debt-to-Equity Ratio, Current Ratio and Debt Service Coverage Ratio based on the financial statements of W.E.T. Automotive Systems (China) Limited, as defined by the DEG Loan agreement.

The Company’s capital lease agreement for an enterprise resource planning system ended in May. A new lease agreement for an enterprise resource planning system commenced June, 2013 and will end May, 2015. Under the terms of the lease, the Company must maintain certain financial covenants. Ownership of the system will be transferred to the Company at the end of the agreement.

No amounts were outstanding under either the US Revolving Note or the W.E.T. Revolving Note as of September 30, 2013 and $29,550 and €20,000 were available under each note, respectively. Gentherm has an outstanding Letter of Credit of $450 as of September 30, 2013.

The following table summarizes the Company’s debt at September 30, 2013 and at December 31, 2012.

	September 30, 2013						December 31, 2012
	Interest Rate			Principal Balance			Principal Balance
US Term Note		2.50	%	$	25,813		$	29,312
Europe Term Note		2.50	%		40,507			4,476
W.E.T. Term Note		2.00	%		12,897			18,852
DEG Loan		4.25	%		5,403			—
Capital Leases		4.20	%		2,814			1,140
Bank of China					—			3,172
Total debt					87,434			56,952
Current portion					(22,164	)		(17,218	)
Long-term debt, less current maturities				$	65,270		$	39,734

As of September 30, 2013, we were in compliance with all terms as outlined in the credit agreement for each of the US Bank of America credit facility, the W.E.T. Bank of America credit facility, the DEG loan and the capital lease agreement.

Note 7 – Derivative Financial Instruments

We are exposed to market risk from changes in foreign currency exchange rates, short term interest rates and price fluctuations of certain material commodities such as copper. Foreign currency exchange risks are attributable to sales to foreign customers not denominated in the seller’s functional currency, foreign plant operations, intercompany indebtedness and purchases from foreign suppliers and include exposures to the European Euro, Canadian Dollar, Japanese Yen, Hungarian Forint, Korean Won and Mexican Peso. The Company regularly enters into derivative contracts with the objective of managing its financial and operational exposure arising from this risk by offsetting gains and losses on the underlying exposures with gains and losses on the financial instruments used to hedge them. We do not enter into derivative financial instruments for speculative or trading purposes. Our hedging relationships are formally documented at the inception of the hedge, and hedges must be highly effective in offsetting changes to future cash flows on hedged transactions both at the inception of a hedge and on an ongoing basis to be designated for hedge accounting treatment. We record the ineffective portion of hedging instruments, if any, to other income (expense) in the consolidated condensed statements of operations.

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

Note 7 – Derivative Financial Instruments – Continued

In March 2008, W.E.T. entered into a 10 year currency related interest rate swap (“CRS”) having a notional value of €10,000, or $13,508 as of September 30, 2013, in order to offset the interest rate risk associated with a debt financing which was repaid prior to our acquisition of W.E.T. Under this agreement W.E.T. receives interest equal to the then nine month Euro Interbank Offered Rate (“EURIBOR”), 0.45% at September 30, 2013, plus 1.40% and pays interest equal to the nine month EURIBOR when the exchange rate between the European Euro (“EUR”) and the Swiss Franc (“CHF”), which was 1.23 at September 30, 2013, equals or exceeds 1.46 EUR to the CHF or pays interest equal to the six month EURIBOR plus a premium when this exchange rate is less than 1.46. The premium is calculated as [(1.46 – current EUR/CHF rate)/current EUR/CHF rate] x 100. In 2012, W.E.T. entered into offsetting derivative contracts designed to cancel out the payment due under the CRS through the end of the CRS agreement, in 2018.

In September 2011, W.E.T. brought a lawsuit against UniCredit Bank AG (“UniCredit”), a past financial advisor, stemming from the recommendation to invest in the aforementioned CRS. On March 25, 2013, the Munich District Court in Munich, Germany ruled in favor of W.E.T., asserting that UniCredit violated its duty to properly advise W.E.T. with respect to the initial negative market value for the CRS and UniCredit’s inherent conflict of interest in recommending that W.E.T. invest in CRS. The Munich District Court ruled that UniCredit must (1) pay €144 to W.E.T. and (2) bear the costs of all future obligations under the CRS, which were €8,906 or $12,030 as of September 30, 2013, plus additional accrued liabilities for past due payments under the CRS of approximately €4,930, or $6,659 as of September 30, 2013. UniCredit has appealed the decision. As a result, the Company cannot be certain that any portion of the decision by the Munich District Court will be realized by W.E.T. See the derivatives table below for information about our future obligations under the CRS as of September 30, 2013.

In July 2011, the Company entered into a series of interest rate swap contracts designated as cash flow hedges and an interest rate cap agreement in order to hedge the exposure to variable market interest rates on the Company’s senior debt. Gains and losses reported in accumulated other comprehensive income will be reclassified to earnings once the Company’s senior debt is repaid.

The Company uses a market approach to value derivative instruments, analyzing observable benchmark rates at commonly quoted intervals for the instrument’s full term.

Information related to the recurring fair value measurement of derivative instruments in our consolidated balance sheet as of September 30, 2013 is as follows:

			Asset Derivatives			Liability Derivatives				Net Asset/ (Liabilities)
	Hedge Designation	Fair Value Hierarchy	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
CRS	Not a hedge	Level 2				Current liabilities	$	(2,476	)
						Non current liabilities		(9,553	)
Total CRS							$	(12,029	)	$	(12,029	)
Foreign currency derivatives	Not a hedge	Level 2	Current assets	$	3	Current liabilities	$	(57	)	$	(54	)
Foreign currency derivatives	Not a hedge	Level 2	Current assets	$	289					$	289
			Non current assets		2,403					$	2,403
Total foreign currency derivatives				$	2,695		$	(57	)	$	2,638
Interest rate swap derivatives	Cash flow hedge	Level 2				Current liabilities	$	(119	)	$	(119	)

GENTHERM INCORPORATED

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

Note 7 – Derivative Financial Instruments – Continued

Information relating to the effect of derivative instruments on our consolidated income statements is as follows:

	Location	Three Months Ended September 30, 2013			Nine Months Ended September 30, 2013
Foreign currency derivatives	Revaluation of derivatives	$	581		$	(694	)
	Foreign currency gain (loss)		(426	)		(844	)
Total foreign currency derivatives		$	155		$	(1,538	)
CRS	Revaluation of derivatives	$	(364	)	$	1,895
Commodity derivatives	Revaluation of derivatives	$	—		$	—
Interest Rate Swap	Interest Expense	$	8		$	8
	Other Comprehensive Income	$	30		$	105

	Location	Three Months Ended September 30, 2012			Nine Months Ended September 30, 2012
Foreign currency derivatives	Revaluation of derivatives	$	(2,036	)	$	(2,514	)
	Foreign currency gain (loss)		1,051			1,722
Total foreign currency derivatives		$	(985	)	$	(792	)
CRS	Revaluation of derivatives	$	1,045		$	1,315
Commodity derivatives	Revaluation of derivatives	$	(2	)	$	143
Interest Rate Swap	Interest Expense	$	(12	)	$	(54	)
	Other Comprehensive Income	$	(25	)	$	(55	)

We did not incur any hedge ineffectiveness during the nine months ended September 30, 2013 and 2012.

Note 8 – Fair Value Measurement

The Company bases fair value on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. We have adopted a fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described below:

Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.

Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.

Level 3: Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.

In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible and also considers counterparty credit risk in its assessment of fair value.

The Company’s derivative instruments and hedging activities and pension assets qualify as financial assets and liabilities whose fair value is measured on a recurring basis each reporting period. Fair value measurement disclosures for our derivative instruments and hedging activities are located within Note 7. The carrying amounts of financial instruments comprising cash and cash equivalents, short-term investments and accounts receivable approximate their fair values due to their short-term nature. The carrying value of the Company’s long-term debt approximates its fair value because interest charged on the loan balance is variable. There were no significant changes to interest rates during the period.

Certain Company assets are required to be recorded at fair value on a non-recurring basis when events and circumstances indicate that the carrying value may not be recoverable. As of September 30, 2013 and 2012, the Company did not realize any changes to the fair value of these assets due to events that negatively impacted their recoverability.

FORWARD LOOKING STATEMENTS

Certain matters discussed or referenced in this report, including expectations of future revenues, our financing requirements, our capital expenditures, our potential acquisitions and our prospects for the development of new products, new customers or new orders from existing customers, are forward-looking statements. Other forward-looking statements may be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “believe”, “estimate”, “anticipate”, “intend”, “continue”, or similar terms, variations of such terms or the negative of such terms. All forward-looking statements speak only as of the date of this report, and we expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained in this report to reflect any change in our expectations with regard to such statements or any change in events, conditions or circumstances on which any such statement is based. Although such statements are based upon our current expectations, and we believe such expectations are reasonable, such expectations, and the forward-looking statements based on them, are subject to a number of factors, risks and uncertainties that could cause our actual results to differ materially from those described in the forward-looking statements, including those described below and in our other filings with the Securities and Exchange Commission.

ITEM 2.

MANAGEMENT ’S DISCUSSION A ND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

General

Gentherm Incorporated designs, develops, manufactures and markets proprietary thermal seat comfort systems and cable systems for sale to automobile and truck original equipment manufacturers (“OEMs”). The Company’s current reportable segments are Climate Controlled Seats (“CCS”), Advanced Technology and W.E.T. CCS represents historical Gentherm’s seat climate control systems, which are designed to improve the temperature comfort of automobile passengers. The CCS segment includes sales of our heated and cooled cup holder and heated and cooled mattress, both of which utilize our proprietary thermoelectric device (“TED”) technology.

Advanced Technology represents a division of the Company engaged in research and development efforts to improve the efficiency of TEDs and to develop, market and distribute products based on this technology.

W.E.T., a German publicly traded company based in Odelzhausen, Germany, is a subsidiary of Gentherm. W.E.T.’s primary product categories include automotive seat comfort systems and specialized automotive cable systems. The automotive seat comfort systems category includes automotive seat heaters, climate comfort systems (similar to Gentherm’s climate controlled seat technology) for automotive seats, automotive steering wheel heater systems and integrated electronic components. The specialized automotive cable systems category includes ready-made wire harnesses and related wiring products.

On February 22, 2013, historical Gentherm acquired an additional 442,253 shares in W.E.T., representing approximately 14% of the total outstanding shares in W.E.T., through a transaction agreement with W.E.T.’s largest minority shareholder. The Company paid 3,300,000 shares of Gentherm common stock and cash of €5,408,000 or $7,247,000 for these shares. As of June 30, 2013, we had acquired an additional 309,460 shares in W.E.T., raising our total ownership interest in W.E.T. above 99%. These additional shares were purchased at a price of €85 per share for a total of €26,304,000 or $35,247,000. Gentherm borrowed an additional $40,441,000 from the US Bank of America credit facility in connection with the purchase of these shares. See Note 6 of the accompanying Notes to Unaudited Consolidated Condensed Financial Statements for additional information about the US Bank of America credit facility.

Management is currently in the process of developing new segments based on future integration plans for W.E.T. and a new global strategy.

Third Quarter 2013 Compared with Third Quarter 2012

The Company’s reportable segments are as follows:

·	W.E.T. Automotive AG (W.E.T.) – W.E.T. is being evaluated currently as an individual segment until such time as Gentherm is able to fully evaluate and implement its future integration plans and strategy.

The following table presents segment information about the reported product revenues and operating income of the Company for the three month period ended September 30, 2013 and 2012.

Three Months Ended September 30,	CCS		Advanced Technology			W.E.T.		Reconciling Items			Consolidated Total
	(In Thousands)
2013:
Product revenues	$	37,697	$	—		$	133,485	$	—		$	171,182
Depreciation and amortization		437		117			6,870		313			7,737
Operating income (loss)		11,152		(1,544	)		11,297		(6,351	)		14,554
2012:
Product revenues	$	33,966	$	—		$	107,092	$	—		$	141,058
Depreciation and amortization		329		82			6,692		342			7,445
Operating income (loss)		9,328		(1,631	)		8,249		(5,908	)		10,038

Product Revenues . Product revenues for the three months ended September 30, 2013 (“Third Quarter 2013”) were $171,182,000 compared with product revenues of $141,058,000 for the three months ended September 30, 2012 (“Third Quarter 2012”), an increase of $30,124,000, or 21%. Product revenues for CCS increased by $3,731,000 or 11%, compared to Third Quarter 2012 while product revenues of W.E.T. grew by $26,393,000, or 25%. Higher CCS sales were due to program launches since Third Quarter 2012 including the Cadilac CTX and the North American variant of the Hyundai Sonata and additional volume on programs launched during Third Quarter 2012 including the redesigned Land Rover Range Rover, Nissan Pathfinder and Infiniti JX. Production volumes on existing vehicle platforms were higher in North America but lower in Japan. The weakness in Japan primarily reflected certain mature vehicle programs that are expected to be refreshed in the coming months. W.E.T. product revenue increases resulted from strong automotive volumes in North America and Asia and continued market penetration in the automotive cable business. W.E.T.’s European based sales were 12% higher than the prior year despite local economic weakness partly due to the market penetration or the cable business. Included in these amounts are W.E.T.’s climate controlled seat products that include heated and cooled as well as heated and ventilated seats which grew 33% to approximately $36,000,000 during the third quarter. Foreign currency translation of our Euro denominated product revenue for Third Quarter 2013, which was approximately €35,683,000 verses €31,855,000 during Third Quarter 2012, benefited our product revenue results by approximately $2,612,000. The average US Dollar/Euro exchange rate for Third Quarter 2013 was 1.3244 versus 1.2512 for Third Quarter 2012.

Cost of Sales. Cost of sales increased to $125,265,000 in Third Quarter 2013 from $104,203,000 in Third Quarter 2012. This increase of $21,062,000, or 20%, is due to increased sales volume partially offset by a higher gross margin percentage. A favorable change in product mix and favorable coverage of fixed manufacturing costs at the higher volume levels were partially offset by costs to establish a new electronics production facility in Shenzhen, China contributed to the higher gross profit percentage during Third Quarter 2013. The electronics facility will produce products for our existing business in the coming quarters and is expected to generate new product revenue streams in future periods.

Net Research and Development Expenses. Net research and development expenses were $12,718,000 during Third Quarter 2013 compared to $10,257,000 in Third Quarter 2012, an increase of $2,461,000, or 24%. This increase is primarily driven by additional resources, including personnel, focused on application engineering for new production programs on existing products, development of new products, start-up costs for the new electronic production facility and a program to develop the next generation of seat comfort products using the best ideas and designs of the combined Gentherm and W.E.T. systems. New product development includes automotive heated and cool storage devices, automotive interior thermal management devices, medical thermal management devices, battery thermal management devices and other potential products.

We classify development and prototype costs and related reimbursements as research and development. This is consistent with accounting standards applied in the automotive industry. Depreciation costs for tooling are included in cost of sales.

Acquisition Transaction Expenses. We incurred $326,000 in fees, legal and other expenses associated with the acquisition of W.E.T. shares during Second Quarter 2013 and subsequent squeeze-out procedures during the Third Quarter 2013. We did not incur any acquisition transaction expenses during Third Quarter 2012.

Selling, General and Administrative Expenses. Selling, general and administrative expenses increased to $18,319,000 in Third Quarter 2013 from $16,560,000 in Third Quarter 2012, an increase of $1,759,000, or 11%. Increases in expenses are due to higher legal, audit and travel costs, as well as wages and benefits costs resulting from new employee hiring and merit increases. The additional employees are primarily related to establishing a new electronics production facility in Shenzhen, China, increasing sales and marketing efforts aimed at supporting our current product development strategy and the ongoing integration process between historical Gentherm and W.E.T. We believe that our selling, general and administrative costs will level off as we work through the integration process and implement cost reduction initiatives enabled by this integration over the next three years.

Income Tax Expense. We recorded an income tax expense of $3,600,000 during Third Quarter 2013 representing an effective tax rate of 29% on earnings before income tax of $12,365,000. This effective tax rate was lower than the US Federal rate of 34% primarily due to the impact of lower statutory rates for our subsidiaries operating in foreign jurisdictions. During the Third Quarter 2012, we recorded an income tax expense of $2,366,000 representing an effective tax rate of 29% on earnings before income tax of $8,039,000. Our effective tax rate was estimated based upon a forecast of our full year results.

Nine Months Ending September 30, 2013 Compared with Nine Months Ending September 30, 2012

The following table presents segment information about the reported product revenues and operating income of the Company for the nine month period ended September 30, 2013 and 2012.

Nine Months Ended September 30,	CCS		Advanced Technology			W.E.T.		Reconciling Items			Consolidated Total
	(In Thousands)
2013:
Product revenues	$	103,460	$	—		$	376,332	$	—		$	479,792
Depreciation and amortization		1,115		344			21,143		865			23,467
Operating income (loss)		28,953		(5,174	)		28,407		(19,422	)		32,764
2012:
Product revenues	$	96,117	$	—		$	310,620	$	—		$	406,737
Depreciation and amortization		787		388			20,697		865			22,737
Operating income (loss)		25,037		(5,260	)		22,274		(14,962	)		27,089

Product Revenues . Product revenues for the nine months ended September 30, 2013 (“YTD 2013”) were $479,792,000 compared with product revenues of $406,737,000 for the nine months ended September 30, 2012 (“YTD 2012”), an increase of $73,055,000, or 18%. Product revenues for CCS increased by $7,343,000 or 8% while product revenues for W.E.T. grew by $65,712,000, or 21%, compared to YTD 2012. Higher CCS revenue was primarily driven by new program launches since YTD 2012 including the Cadilac CTX and the newly redesigned Land Rover Range Rover and additional volume on programs launched during First Half 2012 including the Nissan Pathfinder and Infiniti JX. Production volumes on existing vehicle platforms were higher in North America but lower in Japan and Korea. The weakness in Japan primarily reflected certain mature vehicle programs that are expected to be refreshed in the coming months. Weakness in Korea was due to a production volume decrease in the Kia K9 program which has experienced poor retail sales during the period. W.E.T. product revenue increases resulted from strong automotive volumes in North America and Asia and continued market penetration in the automotive cable business. W.E.T.’s European based sales were 11% higher than the prior year despite local economic weakness partly due to the market penetration of the cable business. Included in these amounts are W.E.T.’s climate controlled seat products that include heated and cooled as well as heated and ventilated seats which grew 27% to approximately $99,000,000 for YTD 2013. Foreign currency translation of our Euro denominated product revenue for YTD 2013, which was approximately €106,103,000 verses €95,483,000 during YTD 2012, increased the US Dollar reported product revenue by approximately $3,735,000. The average US Dollar/Euro exchange rate for YTD 2013 was 1.3172 versus 1.2820 for YTD 2012.

Cost of Sales. Cost of sales increased to $354,672,000 in YTD 2013 from $303,110,000 in YTD 2012. This increase of $51,562,000, or 17%, is due to increased sales volume offset by higher gross margin percentages. A favorable change in product mix and greater coverage of fixed costs at the higher volume levels increased historical gross profit percentage during YTD 2013 to approximately 26% compared with 25% during YTD 2012. The higher gross profit was partially offset by costs to establish a new electronics production facility in Shenzhen, China. The electronics facility will produce products for our existing business in the coming quarters and is expected to generate new product revenue streams in future periods.

Net Research and Development Expenses. Net research and development expenses were $36,962,000 during YTD 2013 compared to $30,566,000 in YTD 2012, an increase of $6,396,000, or 21%. This increase is primarily driven by additional resources, including personnel, focused on application engineering for new production programs on existing products, development of new products, start-up costs for the new electronic production facility and a program to develop the next generation of seat comfort products using the best ideas and designs of the combined Gentherm and W.E.T. systems. New product development includes automotive heated and cool storage devices, automotive interior thermal management devices, medical thermal management devices, battery thermal management devices and other potential products.

Acquisition Transaction Expenses. We incurred $1,911,000 in fees, legal and other expenses associated with the acquisition of W.E.T. shares and subsequent squeeze out procedures during YTD 2013. These fees included payments totaling $750,000 to the

holders of our Series C Convertible Preferred Stock who waived certain equity offering participation rights allowing for the partial funding of W.E.T. shares with Gentherm common stock. We did not incur any acquisition transaction expenses during YTD 2012.

Selling, General and Administrative Expenses. Selling, general and administrative expenses increased to $53,483,000 in YTD 2013 from $45,972,000 in YTD 2012, an increase of $7,511,000, or 16%. This increase is partially due to the termination amounts paid to the former Chief Executive Officer of W.E.T. who resigned during the Second Quarter 2013. Such amounts totaled approximately $1,800,000. We have also experienced an increase in expenses due to higher general legal, audit and travel costs, as well as wages and benefits costs resulting from new employee hiring and merit increases. The additional employees are primarily related to establishing a new electronics production facility in Shenzhen, China, increasing sales and marketing efforts aimed at supporting our current product development strategy and beginning the integration process between historical Gentherm and W.E.T. We incurred approximately $550,000 in incremental audit and accounting expenses driven by Sarbanes-Oxley compliance implementation for W.E.T. which began during Second Quarter 2012. We believe that our selling, general and administrative costs will level off as we work through the integration process and implement cost reduction initiatives enabled by this integration over the next three years.

Income Tax Expense. We recorded an income tax expense of $6,343,000 during YTD 2013 representing an effective tax rate of 21% on earnings before income tax of $30,545,000. This amount included a one-time benefit resulting from the American Taxpayer Relief Act of 2012 (“the Act”) which was signed into law on January 2, 2013. The Act restored the research and development credit and certain exemption under the foreign income tax rules, retroactively to the beginning of 2012. As a result, we recognized approximately $1,300,000 in benefits associated with our 2012 tax year during YTD 2013. Had the Act been adopted during 2012, the benefit would have been recorded during that year and YTD 2013 effective tax rate would have been 25%. This effective tax rate was lower than the US Federal rate of 34% primarily due to the impact of lower statutory rates for our subsidiaries operating in foreign jurisdictions. During YTD 2012, we recorded an income tax expense of $7,324,000 representing an effective tax rate of 28% on earnings before income tax of $25,939,000. Our effective tax rate was estimated based upon a forecast of our full year results.

Liquidity and Capital Resources

The following table represents our cash and cash equivalents and short-term investments which are available for our business operations:

	September 30, 2013		December 31, 2012
	(In thousands)
Cash and cash equivalents	$	36,003	$	58,152

We manage our cash and cash equivalents in order to fund operating requirements and preserve liquidity to take advantage of future business opportunities. Cash and cash equivalents decreased by $22,149,000 in YTD 2013. As of September 30, 2013, the Company had approximately $18,472,000 in cash and cash equivalent at foreign locations. If those cash and cash equivalents were needed for our operations in the U.S. in the future we would be required to accrue and pay U.S. taxes in order to repatriate these funds. Based on our current plans, we believe we have sufficient cash in the U.S. to fund our U.S. operations and our intent is to permanently reinvest these foreign amounts outside of the U.S.

Cash provided by operating activities during YTD 2013 was $28,617,000 and was attributable to net income of $24,202,000, net of non-cash adjustments. Non-cash adjustments included depreciation and amortization of $23,467,000, deferred tax benefits of $1,138,000, gains on revaluation of financial derivatives of $2,859,000 and stock compensation of $1,861,000.

As of September 30, 2013, working capital was $113,354,000 compared to $124,935,000 at December 31, 2012, a decrease of $11,581,000, or 9%. Decreases in cash and cash equivalents and increases to accounts payable and current maturities of long-term debt of $22,149,000, $11,250,000 and $4,946,000, respectively, were partially offset by increases in accounts receivable, inventory and prepaid expenses and other assets of $19,606,000, $8,824,000 and $2,458,000. Account receivable increased primarily as a result of increases in product revenues and timing differences between when sales in YTD 2013 were realized compared with sales realized during the three months ended December 31, 2012 (“Fourth Quarter 2012”). Gentherm incurred proportionally more sales in the last month of Third Quarter 2013 compared with the last month of Fourth Quarter 2012 due to the year-end holiday season. Current maturities of long-term debt increased due to draws made on our US Bank of America Credit Facility to finance the purchase of outstanding shares of W.E.T. held by non-controlling interests. See General under Management’s Discussion and Analysis of Financial Condition and Results of Operations for additional information about the acquisition of W.E.T. shares. During YTD 2013, cash was used to make payments on our outstanding term notes and Series C Convertible Preferred Stock. Total payments on outstanding borrowings were $18,966,000 and total Series C Convertible Preferred Stock payments were $9,142,000. Working Capital also increased by changes in currency exchange rates.

Cash used in investing activities was $77,110,000 during YTD 2013, reflecting the purchase of W.E.T. shares from non-controlling interests totaling $46,835,000 and purchases of property and equipment totaling $30,016,000. Purchases of property and equipment for the period are primarily related to expansion of production capacity, including equipment and leasehold improvements for the new electronics manufacturing facility in Shenzhen, China, the purchase of our world headquarters buildings, and the replacement of existing equipment.

Cash provided by financing activities was $25,030,000 during YTD 2013, reflecting additional borrowings from our US Bank of America Credit Facility and a new loan with the German Investment Corporation (“DEG”) totaling $48,923,000 and proceeds from the exercise of common stock options of $2,901,000. These amounts were partially offset by repayments on our outstanding term notes and Bank of China loan and Series C Convertible Preferred stock totaling $18,966,000 and $9,142,000, respectively.

Series C Convertible Preferred Stock installments paid in cash during the nine month period ended September 30, 2013 are as follows (in thousands):

	Installment Payments ($)
Dividend	$	696
Principal		8,446
Total	$	9,142

In March 2013, holders of the Series C Convertible Preferred Stock elected to covert 165 shares into shares of common stock at the conversion price of $15.83 per share. The Company issued approximately 105,000 shares of common stock related to the conversion of Series C Convertible Preferred Stock.

During the months of July and August 2013, holders of the Series C Convertible Preferred Stock elected to convert all unredeemed remaining shares into shares of common stock at the conversion price of $15.83 per share. The Company issued approximately 432,000 shares of common stock related to the conversion of Series C Convertible Preferred Stock.

The Company has two outstanding credit agreements with a syndicate of banks led by Bank of America; the US Bank of America credit facility and the W.E.T. Bank of America credit facility. The US Bank of America credit facility consists of the US Term Note and Europe Term Note. These notes are subject to quarterly principal payments, with total principal amortization of 10% of the original principal amount in the first year and amortization of 12.5%, 15%, 17.5% and 20% of the original principal amount during years two, three, four and five, respectively with all remaining amounts owing under each term facility due and payable in full at the term loan maturity date. The W.E.T. Bank of America credit facility consists of the W.E.T. Term Note, which is subject to quarterly principal payments totaling 20% annually. Principal outstanding under both the US Bank of America credit facility and W.E.T. Bank of America credit facility will be due and payable in full on March 30, 2016. Interest is payable quarterly. The Company has the option to elect interest rates based on either a Eurocurrency (LIBOR or EURIBOR) rate (“Eurocurrency Rate Loans”) (0.17% – 0.45% at September 30, 2013) or a base rate (“Base Rate Loans”) plus a margin (“Applicable Rate”), which varies based on the Consolidated Leverage Ratio of the Company, as defined by the US and W.E.T. Bank of America credit agreements. The base rate is equal to the highest of the Federal Funds Rate (0.06% at September 30, 2013) plus 0.5%, Bank of America’s prime rate (3.25% at September 30, 2013), or a one month Eurocurrency rate plus 1.0%. The Applicable Rate for the current period was 2.25% for Eurocurrency Rate Loans and 1.25% for Base Rate Loans. The Company must maintain a minimum Consolidated Fixed Charge Coverage Ratio and a maximum Leverage Ratio, as defined by the Bank of America credit agreement. The loans are secured by all of the Company’s assets.

In February 2013, the Company made a $40,441,000 draw on the existing Europe Term Note portion of the US Bank of America credit facility to finance the purchase of shares of WET held by non-controlling interests. The Europe Term Note has expired and additional draws are not available to Gentherm.

In September 2012, we borrowed CN¥20,000,000 or $3,159,000 from Bank of China to fund a plant expansion project in China. The Bank of China loan was paid in full on September 10, 2013 with interest calculated at a fixed rate of 6.9%.

In May 2013, the Company made an initial draw of €2,000,000, or $2,601,000, on a loan from the German Investment Corporation, a subsidiary of KfW banking group, a German government-owned development bank (“DEG Loan”), to fund the China plant expansion project. An additional draw of €2,000,000, or $2,701,000, was made in September and the entire loan balance was

rolled into a fixed interest rate loan with an interest rate of 3% plus a Euro Swap Rate of 1.25%. The Bank of China short term financing used to complete the project was repaid from funds available under the DEG Loan. The DEG Loan is subject to semi-annual principal payments beginning March, 2015 and ending September, 2019. Under the terms of the loan, the Company must maintain a minimum Debt-to-Equity Ratio, Current Ratio and Debt Service Coverage Ratio based on the financial statements of W.E.T. Automotive Systems (China) Limited, as defined by the DEG Loan agreement. As of September 30, 2013, the entire DEG loan has been spent on the plant expansion project, which is now complete.

No amounts were outstanding under either the US Revolving Note or the W.E.T. Revolving Note as of September 30, 2013 and $29,550,000 and €20,000,000 were available under each note, respectively. Gentherm also has an outstanding Letter of Credit of $450,000 as of September 30, 2013.

The following table summarizes the Company’s debt at June 30, 2013 and December 31, 2012 (in thousands).

	September 30, 2013						December 31, 2012
	Interest Rate			Principal Balance			Principal Balance
US Term Note		2.50	%	$	25,813		$	29,312
Europe Term Note		2.50	%		40,507			4,476
W.E.T. Term Note		2.00	%		12,897			18,852
DEG Loan		4.25	%		5,403			—
Capital Leases		4.20	%		2,814			1,140
Bank of China					—			3,172
Total debt					87,434			56,952
Current portion					(22,164	)		(17,218	)
Long-term debt, less current maturities				$	65,270		$	39,734

The Company has funded its financial needs from inception primarily through net proceeds received through its initial public offering as well as other equity and debt financing activities. Based on its current operating plan, management believes cash and equivalents at September 30, 2013 along with proceeds from future revenues are sufficient to meet operating needs for the foreseeable future.

Recent Accounting Pronouncement

Hedge Accounting

We do not anticipate that the adoption of this guidance will have a material effect on our consolidated balance sheet or statement of operations.

Unrecognized Tax Benefits

Tax Regulation

ITEM 3.

QUANTITATIVE A ND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are exposed to market risk from changes in foreign currency exchange rates, short term interest rates and price fluctuations of certain material commodities, such as copper. Market risks for changes in interest rates relate primarily to our debt obligations under our Bank of America credit facilities. Foreign currency exchange risks are attributable to sales to foreign customers not denominated in the seller’s functional currency, foreign plant operations, intercompany indebtedness and purchases from foreign suppliers and include exposures to the European Euro, Mexican Peso, Canadian Dollar, Hungarian Forint and Korean Won. Our subsidiary W.E.T. regularly enters into derivative contracts with the objective of managing its financial and operational exposure arising from this risk by offsetting gains and losses on the underlying exposures with gains and losses on the financial instruments used to hedge them. While W.E.T. continuously monitors the hedging program, derivative positions and hedging strategies and maintains documentation as to the hedging objectives, practices and procedures, W.E.T. has not typically designated its derivatives as hedging instruments for accounting purposes.

In March 2008, W.E.T. entered into a 10 year currency related interest rate swap (“CRS”) having a notional value of €10,000,000 or $13,508,000 as of September 30, 2013, in order to offset the interest rate risk associated with a debt financing which was repaid prior to our acquisition of W.E.T. Under this agreement W.E.T. receives interest equal to the then nine month Euro Interbank Offered Rate (“EURIBOR”), 0.45% at September 30, 2013, plus 1.40% and pays interest equal to the nine month EURIBOR when the exchange rate between the European Euro (“EUR”) and the Swiss Franc (“CHF”), which was 1.23 at September 30, 2013, equals or exceeds 1.46 EUR to the CHF or pays interest equal to the six month EURIBOR plus a premium when this exchange rate is less than 1.46. The premium is calculated as [(1.46 – current EUR/CHF rate)/current EUR/CHF rate] x 100. W.E.T. has entered into offsetting derivative contracts designed to cancel out the payment due under the CRS through the end of the CRS agreement, in 2018.

In September 2011, W.E.T. brought a lawsuit against UniCredit Bank AG (“UniCredit”), a past financial advisor, stemming from the recommendation to invest in the aforementioned CRS. On March 25, 2013, the Munich District Court in Munich, Germany ruled in favor of W.E.T., asserting that UniCredit violated its duty to properly advise W.E.T. with respect to the initial negative market value for the CRS and UniCredit’s inherent conflict of interest in recommending that W.E.T. invest in CRS. The Munich District Court ruled that UniCredit must (1) pay €144,000 to W.E.T. and (2) bear the costs of all future obligations under the CRS, which were €8,906,000 or $12,030,000 as of September 30, 2013, plus additional accrued liabilities for past due payments under the CRS of approximately €4,930,000, or $6,659,000 as of September 30, 2013. UniCredit has appealed the decision and an extension has been granted. As a result, the Company cannot be certain that any portion of the award by the Munich District Court will be realized by W.E.T. See the derivatives table below for information about our future obligations under the CRS as of September 30, 2013.

Contract Type	Contract Term	(in thousands) Notional Value		Hedged Instruments	Fixed Rate			Variable Rate	Rate Cap
Swap	June 30, 2014	$	8,000	US Term Note		1.27	%	3 month LIBOR		—
Swap	June 30, 2014	$	8,000	US Term Note		1.27	%	3 month LIBOR		—
Cap	March 31, 2016	€	14,250	W.E.T. Term Note		—		3 month EURIBOR		2.75

The Company uses a market approach to value derivative instruments, analyzing observable benchmark rates at commonly quoted intervals for the instrument’s full term. Information related to the fair values of derivative instruments in our consolidated balance sheet as of September 30, 2013 is as follows (in thousands):

			Asset Derivatives			Liability Derivatives				Net Asset/ (Liabilities)
	Hedge Designation	Fair Value Hierarchy	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
CRS	Not a hedge	Level 2				Current liabilities	$	(2,476	)
						Non current liabilities		(9,553	)
Total CRS							$	(12,029	)	$	(12,029	)
Foreign currency derivatives	Not a hedge	Level 2	Current assets	$	3	Current liabilities	$	(57	)	$	(54	)
Foreign currency derivatives	Not a hedge	Level 2	Current assets	$	289					$	289
			Non current assets		2,403					$	2,403
Total foreign currency derivatives				$	2,695		$	(57	)	$	2,638
Interest rate swap derivatives	Cash flow hedge	Level 2				Current liabilities	$	(119	)	$	(119	)

Information related to the effect of derivative instruments on our consolidated income statements is as follows (in thousands):

	Location	Three Months Ended September 30, 2013			Nine Months Ended September 30, 2013
Foreign currency derivatives	Revaluation of derivatives	$	581		$	(694	)
	Foreign currency gain (loss)		(426	)		(844	)
Total foreign currency derivatives		$	155		$	(1,538	)
CRS	Revaluation of derivatives	$	(364	)	$	1,895
Commodity derivatives	Revaluation of derivatives	$	—		$	—
Interest Rate Swap	Interest Expense	$	8		$	8
	Other Comprehensive Income	$	30		$	105

	Location	Three Months Ended September 30, 2012			Nine Months Ended September 30, 2012
Foreign currency derivatives	Revaluation of derivatives	$	(2,036	)	$	(2,514	)
	Foreign currency gain (loss)		1,051			1,722
Total foreign currency derivatives		$	(985	)	$	(792	)
CRS	Revaluation of derivatives	$	1,045		$	1,315
Commodity derivatives	Revaluation of derivatives	$	(2	)	$	143
Interest Rate Swap	Interest Expense	$	(12	)	$	(54	)
	Other Comprehensive Income	$	(25	)	$	(55	)

We did not incur any hedge ineffectiveness during the three months ended September 30, 2013 and 2012.

Interest Rate Sensitivity

The table below provides information about the Company’s debt obligations, derivative financial instruments and other financial instruments that are sensitive to changes in interest rates. For debt and capital lease obligations, the table presents principal cash flows and related weighted average interest rates by expected maturity dates. For interest rate swaps, the table presents notional amounts and weighted average interest rates by expected (contractual) maturity dates. Notional amounts are used to calculate the contractual payments to be exchanged under the contract. Weighted average variable rates are based on implied forward rates in the yield curve at the reporting date. The information is presented in U.S. dollar equivalents, which is the Company’s reporting currency. The instruments actual cash flows are denominated in U.S. dollars ($USD), European Euros (€EUR) and Chinese Yuan Renminbi (¥CNY) as indicated in parentheses.

September 30, 2013

	Expected Maturity Date
	2013			2014			2015			2016			2017			2018			2019			Total			Fair Value

	(In Thousands except rate information)
Liabilities
Long Term Debt:
Fixed Rate (€EUR)	$	511		$	1,626		$	677		$	—		$	—		$	—		$	—		$	2,814		$	2,814
Average Interest Rate		4.20	%		4.20	%		4.20	%		0.00	%		0.00	%		0.00	%		0.00	%		4.20	%
Fixed Rate (¥CNY)	$	—		$	540		$	1,081		$	1,081		$	1,081		$	1,080		$	540		$	5,403		$	5,403
Average Interest Rate		0.00	%		4.25	%		4.25	%		4.25	%		4.25	%		4.25	%		4.25	%		4.25	%
Variable Rate ($USD)	$	3,532		$	15,070		$	16,956		$	34,376		$	—		$	—		$	—		$	69,934		$	69,934
Average Interest Rate		2.44	%		2.44	%		2.44	%		2.44	%		0.00	%		0.00	%		0.00	%		2.44	%
Variable Rate (€EUR)	$	1,522		$	4,555		$	859		$	2,347		$	—		$	—		$	—		$	9,283		$	9,284
Average Interest Rate		2.17	%		2.17	%		2.17	%		2.17	%		0.00	%		0.00	%		0.00	%		2.17	%
Derivative Financial Instruments:
Interest Rate Swap ($USD)	$	21		$	38		$	—		$	—		$	—		$	—		$	—		$	59		$	59
Average Interest Rate		0.27	%		0.33	%		0.00	%		0.00	%		0.00	%		0.00	%		0.00	%		0.29	%
Interest Rate Swap ($USD)	$	20		$	39		$	—		$	—		$	—		$	—		$	—		$	59		$	59
Average Interest Rate		0.36	%		0.40	%		0.00	%		0.00	%		0.00	%		0.00	%		0.00	%		0.38	%
Interest Rate Cap (€EUR)	$	—		$	—		$	—		$	3		$	—		$	—		$	—		$	3		$	3
Average Interest Rate		0.00	%		0.00	%		0.00	%		2.75	%		0.00	%		0.00	%		0.00	%		2.75	%

Exchange Rate Sensitivity

The table below provides information about the Company’s derivative financial instruments and other financial instruments by functional currency and presents such information in U.S. dollar equivalents. The table summarizes information on instruments and transactions and are sensitive to foreign currency exchange rates, including foreign currency forward exchange agreements, €EUR denominated debt obligations. For debt obligations, the table presents principal cash flows and related weighted average interest rates by expected maturity dates. For foreign currency forward exchange agreements, the table presents the notional amounts and weighted average exchange rates by expected (contractual) maturity dates. These notional amounts generally are used to calculate the contractual payments to be exchanged under the contract.

September 30, 2013

	Expected Maturity or Transaction Date
Anticipated Transactions And Related Derivatives	2013		2014		2015		2016		2017		Thereafter		Total		Fair Value

	(In Thousands except rate information)
Euro functional currency
Forward Exchange Agreements:
(Receive EUR€/Pay USD$)
Total Contract Amount (€)	€	1,082											€	1,082	€	(28	)
Average Contract Rate		1.3860		—		—		—		—		—		1.3860
(Receive HUF/Pay EUR€)
Total Contract Amount (€)	€	2,378											€	2,378	€	37
Average Contract Rate		302.82		—		—		—		—		—		302.82
(Receive CHF/Pay EUR€)
Total Contract Amount (€)	€		€	12,336	€	12,335	€	12,437	€	12,302	€	6,151	€	55,561	€	1,898
Average Contract Rate		—		1.20		1.20		1.20		1.20		1.20		1.20
(Receive EUR€/Pay KRW)
Total Contract Amount (€)	€	2,868											€	2,868	€	(14	)
Average Contract Rate		1,464.53		—		—		—		—		—		1,464.53
$US functional currency
Forward Exchange Agreements:
(Receive CAD$/Pay USD$)
Total Contract Amount ($)	$	2,562											$	4,777	$	(56	)
Average Contract Rate		1.0539		—		—		—		—		—		1.0539
(Receive MXN/Pay USD$)
Total Contract Amount ($)	$	4,530											$	4,530	$	(23	)
Average Contract Rate		13.246		—		—		—		—		—		13.246

ITEM 4.

CONTROLS AND PROCEDURES

(a) Evaluation of Disclosure Controls and Procedures

Our management has evaluated, with the participation of our principal executive and principal financial officers, the effectiveness of our disclosure controls and procedures and of our internal control over financial reporting, both as of September 30, 2013. Based on their evaluation, our principal executive and principal financial officers have concluded that these controls and procedures are effective as of September 30, 2013.

Disclosure controls and procedures and other procedures are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure.

Internal control over financial reporting is a process designed by, or under the supervision of, our principal executive and principal financial officers, and effected by our board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that: (1) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect our transactions and dispositions of assets, (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors, and (3) and provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.

(b) Changes in Internal Control over Financial Reporting

During the fiscal quarter ended September 30, 2013, there was no change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II OT HER INFORMATION

ITEM 1.

LEGA L PROCEEDINGS

We are subject to litigation from time to time in the ordinary course of our business, however, except for the decision of the Munich District Court in favor of W.E.T. against UniCredit Bank AG as reported in our Form 10-Q for the quarter ended March 31, 2013, there is no other current material pending litigation to which we are a party and no material legal proceeding was terminated, settled or otherwise resolved during the nine months ended September 30, 2013.

ITEM 1A.

RISK FACTORS

There were no material changes in our risk factors previously disclosed in Part I, Item 1A. of our Form 10-K for the year ended December 31, 2012.

ITEM 6.

E XHIBITS

Exhibits to this Report are as follows:

Exhibit Number		Description

3.1		Restated Articles of Incorporation (19)

3.2		Amended and Restated Bylaws of the Company (21)

4.1		Rights Agreement dated January 26, 2009 by and between the Company and Computershare Trust Company, N.A., as Rights Agent (9)

4.2		Amendment to Rights Agreement, dated as of March 30, 2011, by and between the Company and Computershare Trust Company, N.A. (11)

10.1*		1993 Stock Option Plan (1)

10.2.1*		Amended and Restated 1997 Stock Incentive Plan (2)

10.2.2*		First Amendment to Amended and Restated 1997 Stock Incentive Plan (5)

10.2.3*		Second Amendment to Amended and Restated 1997 Stock Incentive Plan (5)

10.3.1*		2006 Equity Incentive Plan (4)

10.3.2*		Amendment to 2006 Equity Incentive Plan (6)

10.3.3*		Second Amendment to 2006 Equity Incentive Plan (7)

10.3.4*		Third Amendment to 2006 Equity Incentive Plan (10)

10.3.5*		Fourth Amendment to 2006 Equity Incentive Plan (11)

10.3.6*		Fifth Amendment to 2006 Equity Incentive Plan (16)

10.3.7*		Sixth Amendment to 2006 Equity Incentive Plan (25)

10.3.8*		2011 Equity Incentive Plan (12)

10.3.9*		First Amendment to 2011 Equity Incentive Plan (16)

10.3.10*		Second Amendment to 2011 Equity Incentive Plan (18)

Exhibit Number		Description

10.3.11*		Third Amendment to 2011 Equity Incentive Plan (25)

10.3.12*		2013 Equity Incentive Plan (24)

10.3.13*		Form of 2013 Equity Incentive Plan Stock Option Award Agreement (26)

10.3.14*		Form of 2013 Equity Incentive Plan Stock Appreciation Right Award Agreement (26)

10.3.15*		Form of 2013 Equity Incentive Plan Restricted Stock Award Agreement (26)

10.4		Revenue Sharing Agreement between BSST LLC and Dr. Lon E. Bell dated September 4, 2000 (3)

10.4.1		First Amendment to Revenue Sharing Agreement between the Company and Dr. Lon E. Bell dated December 31, 2010 (13)

10.5*		The Executive Nonqualified Defined Benefit Plan of Gentherm Incorporated effective as of April 1, 2008 (8)

10.6		Balaton Rights Agreement, dated as of February 15, 2013, by and between Deutsche Balaton AG and Gentherm Incorporated (22)

10.7.1		Credit Agreement, dated as of March 30, 2011, by and among the Company, Gentherm Europe GmbH, the financial institutions which are now or which hereafter become a party thereto and Bank of America, N.A., as Swing Line Lender and L/C Issuer, and as administrative agent for the lenders (11)

10.7.2		First Amendment to Credit Agreement, dated as of April 4, 2011, by and among the Company, Gentherm Europe GmbH, the financial institutions which are now or which hereafter become a party thereto and Bank of America, N.A., as Swing Line Lender and L/C Issuer, and as administrative agent for the lenders (15)

10.7.3		Second Amendment to Credit Agreement, dated as of August 12, 2011, by and among the Company, Gentherm Europe GmbH, the financial institutions which are now or which hereafter become a party thereto and Bank of America, N.A., as Swing Line Lender and L/C Issuer, and as administrative agent for the lenders (15)

10.7.4		Third Amendment to Credit Agreement, dated as of October 28, 2011, by and among the Company, Gentherm Europe GmbH, the financial institutions which are now or which hereafter become a party thereto and Bank of America, N.A., as Swing Line Lender and L/C Issuer, and as administrative agent for the lenders (15)

10.7.5		Fourth Amendment to Credit Agreement, dated as of March 12, 2012, by and among the Company, Amerigon Europe GmbH, the financial institutions which are now or which hereafter become a party thereto and Bank of America, N.A., as Swing Line Lender and L/C Issuer, and as administrative agent for the lenders (18)

10.7.6		Fifth Amendment to Credit Agreement, dated as of December 17, 2012, by and among the Company, Amerigon Europe GmbH, the financial institutions which are now or which hereafter become a party thereto and Bank of America, N.A., as Swing Line Lender and L/C Issuer, and as administrative agent for the lenders (20)

10.7.7		Sixth Amendment to Credit Agreement, dated as of August 12, 2013, by and among the Company, Amerigon Europe GmbH, the financial institutions which are now or which hereafter become a party thereto and Bank of America, N.A., as Swing Line Lender and L/C Issuer, and as administrative agent for the lenders (27)

10.7.8		Pledge and Security Agreement, dated as of March 30, 2011, by and among the Company, BSST LLC, ZT Plus, LLC, Gentherm Europe GmbH and Bank of America, N.A. (11)

10.7.9		Parent Guaranty, dated as of March 30, 2011, by the Company and Gentherm Europe GmbH executed in favor of Banc of America Securities Limited, in its capacity as administrative agent (11)

10.8		Credit Agreement, dated as of March 30, 2011, among W.E.T. Automotive Systems AG, W.E.T. Automotive Systems Ltd., Banc of America Securities Limited, et al. (14)

10.8.1		First Amendment to Credit Agreement, dated as of May 31, 2011, among W.E.T. Automotive Systems AG, W.E.T. Automotive Systems Ltd., Banc of America Securities Limited, et al. (15)

10.8.2		Second Amendment to Credit Agreement, dated as of October 11, 2011, among W.E.T. Automotive Systems AG, W.E.T. Automotive Systems Ltd., Banc of America Securities Limited, et al. (15)

10.8.3		Third Amendment to Credit Agreement, dated as of November 14, 2011, among W.E.T. Automotive Systems AG, W.E.T. Automotive Systems Ltd., Banc of America Securities Limited, et al. (17)

Exhibit Number		Description

10.8.4		Fourth Amendment to Credit Agreement, dated as of March 23, 2012, among W.E.T. Automotive Systems AG, W.E.T. Automotive Systems Ltd., Banc of America Securities Limited, et al. (17)

10.8.5		Fifth Amendment to Credit Agreement, dated as of December 17, 2012, among W.E.T. Automotive Systems AG, W.E.T. Automotive Systems Ltd., Banc of America Securities Limited, et al. (20)

10.9.1*		Service Agreement, dated as of July 4, 2011, between W.E.T. Automotive Systems AG and Mr. Frithjof Oldorff, which consolidates the original agreement and first and second amendments thereto (14)

10.9.2*		Third Amendment to Service Agreement between W.E.T. Automotive Systems AG and Mr. Frithjof Oldorff (23)

10.10*		Service Agreement between W.E.T. Automotive Systems AG and Mr. Thomas Liedl

10.11		Registration Rights Agreement, dated as of February 15, 2013, by and between Gentherm Incorporated and Deutsche Balaton AG (22)

31.1		Certification of Chief Executive Officer Required by Rule 13a-14(a)/15d-14(a)

31.2		Certification of Chief Financial Officer Required by Rule 13a-14(a)/15d-14(a)

32.1		Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2		Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS		XBRL Instance Document.

101.SCH		XBRL Taxonomy Extension Schema Document.

101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document.

101.DEF		XBRL Taxonomy Extension Definition Linkbase Document.

101.LAB		XBRL Taxonomy Extension Label Linkbase Document.

101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document.

*	Indicates management contract or compensatory plan or arrangement.

(1)	Previously filed as an exhibit to the Company ’s Registration Statement on Form SB-2, as amended, File No. 33-61702-LA, and incorporated by reference.

(2)	Previously filed as an exhibit to the Company ’s Definitive Proxy Statement on Schedule 14A with respect to the Company’s 2001 Annual Meeting of Stockholders and incorporated herein by reference.

(3)	Previously filed as an exhibit to the Company ’s Quarterly Report on Form 10-Q for the period ended June 30, 2001 and incorporated herein by reference.

(4)	Previously filed as an exhibit to the Company ’s Definitive Proxy Statement on Schedule 14A with respect to the Company’s 2006 Annual Meeting of Stockholders and incorporated herein by reference.

(5)	Previously filed as an exhibit to the Company ’s Current Report on Form 8-K filed May 23, 2005 and incorporated herein by reference.

(6)	Previously filed as an exhibit to the Company ’s Annual Report on Form 10-K for the period ended December 31, 2006 and incorporated herein by reference.

(7)	Previously filed as an exhibit to the Company ’s Current Report on Form 8-K filed March 20, 2007 and incorporated herein by reference.

(8)	Previously filed as an exhibit to t he Company’s Quarterly Report on Form 10-Q filed August 11, 2008 and incorporated herein by reference.

(9)	Previously filed as an exhibit to the Company ’s Current Report on Form 8-K filed January 27, 2009 and incorporated herein by reference.

(10)	Previo usly filed as an exhibit to the Company’s Definitive Proxy Statement on Schedule 14A with respect to the Company’s 2009 Annual Meeting of Stockholders and incorporated herein by reference.

(11)	Previously filed as an exhibit to the Company ’s Current Report on Form 8 filed on March 31, 2011 and incorporated herein by reference

(12)	Previously filed as an exhibit to the Company ’s Definitive Proxy Statement on Schedule 14A with respect to the Company’s 2011 Annual Meeting of Stockholders and incorporated herein by reference.

(13)	Previously filed as an exhibit to the Company ’s Annual Report on Form 10-K filed February 17, 2011 and incorporated herein by reference.

(14)	Previously filed as an exhibit to the Company ’s Current Report on Form 8-K filed August 4, 2011 and incorporated herein by reference.

(15)	Previously filed as an exhibit to the Company ’s Current Report on Form 8-K filed November 1, 2011 and incorporated herein by reference.

(16)	Previously filed as an exhibit to the Company ’s Annual Report on Form 10-K filed March 15, 2012 and incorporated herein by reference.

(17)	Previously filed as an exhibit to the Company ’s Current Report on Form 8-K filed April 4, 2012 and incorporated herein by reference.

(18)	Previously filed as an exhibit to the Co mpany’s Current Report on Form 8-K filed May 11, 2012 and incorporated herein by reference.

(19)	Previously filed as an exhibit to the Company ’s Quarterly Report on Form 10-Q filed November 5, 2012 and incorporated herein by reference.

(20)	Previously fi led as an exhibit to the Company’s Current Report on Form 8-K filed December 21, 2012 and incorporated herein by reference.

(21)	Previously filed as an exhibit to the Company ’s Current Report on Form 8-K filed January 2, 2013 and incorporated herein by reference.

(22)	Previously filed as an exhibit to the Company ’s Current Report on Form 8-K filed February 21, 2013 and incorporated herein by reference.

(23)	Previously filed as an exhibit to the Company ’s Annual Report on Form 10-K filed March 15, 2013 and incorporated herein by reference.

(24)	Previously filed as an exhibit to the Company ’s Definitive Proxy Statement on Schedule 14A with respect to the Company’s 2013 Annual Meeting of Stockholders and incorporated herein by reference.

(25)	Previously fi led as an exhibit to the Company’s Current Report on Form 8-K filed May 20, 2013 and incorporated herein by reference.

(26)	Previously filed as an exhibit to the Company ’s Current Report on Form 8-K filed June 27, 2013 and incorporated herein by reference.

(27)	Previously filed as an exhibit to the Company ’s Current Report on Form 8-K filed August 14, 2013 and incorporated herein by reference.

SIGNA TURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Gentherm Incorporated

(Registrant)

/ S / D ANIEL R. C OKER

Daniel R. Coker

Chief Executive Officer

(Duly Authorized Officer)

Date: November 5, 2013

/ S / B ARRY G. S TEELE

Barry G. Steele

Chief Financial Officer

(Principal Financial Officer and Principal Accounting Officer)

Date: November 5, 2013

TABLE OF CONTENTS

Part I. Financial Information Item 1. Financial Statements Note 1 The Company and Subsequent Event Note 2 Basis Of Presentation and New Accounting Pronouncements Note 2 Basis Of Presentation and New Accounting Pronouncements Continued Note 3 Earnings Per Share Note 4 Segment Reporting Note 4 Segment Reporting Continued Note 5 Series C Convertible Preferred Stock Note 5 Series C Convertible Preferred Stock Continued Note 6 Debt Note 6 Debt Continued Note 7 Derivative Financial Instruments Note 7 Derivative Financial Instruments Continued Note 8 Fair Value Measurement Item 2. Management S Discussion and Analysis Of Financial Condition and Results Of Operations Item 3. Quantitative and Qualitative Disclosures About Market Risk Item 4. Controls and Procedures Part II Other Information Item 1. Legal Proceedings Item 1A. Risk Factors Item 6. Exhibits

THRM 10-Q Quarter ended Sept. 30, 2013